References
- Nkomo VT , GardinJM , SkeltonTNet al. Burden of valvular heart diseases: a population-based study. Lancet368, 1005–1011 (2006).
- Iung B , VahanianA. Epidemiology of acquired valvular heart disease. Can. J. Cardiol.30, 962–970 (2014).
- Stewart BF , SiscovickD , LindBKet al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol.29, 630 (1997).
- Nishimura RA , OttoCM , BonowROet al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J. Am. Coll. Cardiol.70, 252–289 (2017).
- Bozso SJ , KangJJH , MathewAet al. Comparing scaffold design and recellularization techniques for development of tissue engineered heart valves. Regen. Eng. Transl. Med.7, 432–439 (2020).
- Mrsic Z , HopkinsPS , AntevilLJet al. Valvular heart disease. Cardiovasc. Dis.45, 81–94 (2018).
- Starr A , FesslerCL , GrunkemeierGet al. Heart valve replacement surgery: past, present and future. Clin. Exp. Pharmacol. Physiol.29, 735–738 (2002).
- Bozso SJ , El-AndariR , Al-AdraDet al. A review of the immune response stimulated by xenogenic tissue heart valves. Scand. J. Immunol.93(4), e13018 (2020).
- Bozso SSJ , KangJJH , BasuRet al. Structural valve deterioration is linked to increased immune infiltrate and chemokine expression. J. Cardiovasc. Transl. Res.14(3), 503–512 (2020).
- Head SJ , ÇelikM , KappeteinAP. Mechanical versus bioprosthetic aortic valve replacement. Eur. Heart J.38, 2183–2191 (2017).
- Cheung DY , DuanB , ButcherJT. Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin. Biol. Ther.15, 1155–1172 (2015).
- Vesely I . Heart valve tissue engineering. Circ. Res.97(8), 743–755 (2005).
- Schenke-Layland K , VasilevskiO , OpitzFet al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol.143, 201–208 (2003).
- Grauss RW , HazekampMG , OppenhuizenFet al. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur. J. Cardiothorac. Surg.27, 566–571 (2005).
- Simon P , KasimirMT , SeebacherGet al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT® in pediatric patients. Eur. J. Cardiothorac. Surg.23, 1002–1006 (2003).
- Bozso SJ , KangJJH , EL-AndariRet al. Recellularization of xenograft heart valves reduces the xenoreactive immune response in an in vivo rat model. Eur. J. Cardiothorac. Surg.61(2), 427–436 (2021).
- Cebotari S . Clinical Application of tissue engineered human heart valves using autologous progenitor cells. Circulation114, I–137 (2006).
- Kang JJ , BozsoSJ , BoeDEet al. Resveratrol attenuates stimulated T-cell activation and proliferation: potential therapy against cellular rejection in organ transplantation. Am. J. Clin. Exp. Immunol.9, 81–90 (2020).
- Kang JJH , BozsoSJ , El-AndariRet al. Sternal bone marrow harvesting and culturing techniques from patients undergoing cardiac surgery. Micromachines12(8), 897 (2021).
- Griffiths LG , ChoeLH , ReardonKFet al. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials29, 3514 (2008).
- Gates K v , DalglieshAJ , GriffithsLG. Antigenicity of bovine pericardium determined by a novel immunoproteomic approach. Sci. Rep.7, 2410–2446 (2017).
- Bozso SJ , KangJJH , EL‐AndariRet al. Recellularized bovine pericardium with autologous mesenchymal stem cells reduces immune activation. Xenotransplantation29(6), e12774 (2022).
- Sutherland FWH , PerryTE , YuYet al. From stem cells to viable autologous semilunar heart valve. Circulation111, 2783–2791 (2005).
- Vincentelli A , WautotF , JuthierFet al. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J. Thorac. Cardiovasc. Surg. 134, 424–432 (2007).
- Aggarwal S , PittengerMF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood105, 1815–1822 (2005).
- Li N , HuaJ. Interactions between mesenchymal stem cells and the immune system. Cell. Mol. Life Sci.74, 2345–2360 (2017).